Cargando…
Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology
Recent advances in genome engineering based on the CRISPR/Cas9 technology have revolutionized our ability to manipulate genomic DNA. Its use in human pluripotent stem cells (hPSCs) has allowed a wide range of mutant cell lines to be obtained at an unprecedented rate. The combination of these two gro...
Autores principales: | Mianné, Joffrey, Bourguignon, Chloé, Nguyen Van, Chloé, Fieldès, Mathieu, Nasri, Amel, Assou, Said, De Vos, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290981/ https://www.ncbi.nlm.nih.gov/pubmed/32466123 http://dx.doi.org/10.3390/cells9051312 |
Ejemplares similares
-
CRISPR/Cas9-mediated gene knockout and interallelic gene conversion in human induced pluripotent stem cells using non-integrative bacteriophage-chimeric retrovirus-like particles
por: Mianné, Joffrey, et al.
Publicado: (2022) -
Recurrent Genetic Abnormalities in Human Pluripotent Stem Cells: Definition and Routine Detection in Culture Supernatant by Targeted Droplet Digital PCR
por: Assou, Said, et al.
Publicado: (2020) -
Differentiation of Human Induced Pluripotent Stem Cells from Patients with Severe COPD into Functional Airway Epithelium
por: Ahmed, Engi, et al.
Publicado: (2022) -
Targeted therapy in eosinophilic chronic obstructive pulmonary disease
por: Fieldes, Mathieu, et al.
Publicado: (2021) -
A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells
por: Christensen, Chloe L., et al.
Publicado: (2017)